Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
Promising topline results from a phase 3B study show the efficacy and quality of life (QOL) improvements of iptacopan ...
AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 g/dL for the ...
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
Chronic anemia can leave you feeling tired, weak, and unable to concentrate. It happens when your body doesn’t have enough ...
The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...
Anemia, a prevalent health concern globally, arises from low hemoglobin levels, often resulting in debilitating symptoms such ...
Anemia remains a major cause of mortality and morbidity in developing countries where resources to determine the underlying etiology remain poor. There are three basic mechanisms for developing ...